Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: XOMA

XOMA Royalty Corp.

Healthcare | Biotechnology

No licensed closing price on file for XOMA. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$1.57

XOMA Royalty Corp. (NASDAQ: XOMA) is a biotechnology company. Figures from SEC EDGAR; updated 2026-10-20 07:15 UTC.

What XOMA Royalty Corp. does

XOMA is a royalty aggregator that provides non-dilutive funding to biotech companies in exchange for the right to receive future milestone and royalty payments from their drug candidates and approved products. The company maintains a diversified portfolio of economic interests in over 120 assets across various development stages, including seven commercial-stage products and fourteen late-stage therapeutic candidates.

Summarized from XOMA Royalty Corp.’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

XOMA no longer appears among SEC's registered filers -- it may have been acquired, merged, or delisted. The figures on this page reflect the company's final filings and are no longer refreshed.

Key facts

Valuation
EPS (TTM)$1.57
Return on equity37.78%
Debt/equity0.96

Revenue, margins & earnings

FY2021 Net income: $16MFY2021 Taxes & interest: $2MFY2021 Operating costs: $21M$38MFY2021FY2022: net loss $17M on revenue $6M$6MFY2022FY2023: net loss $41M on revenue $5M$5MFY2023FY2024: net loss $14M on revenue $28M$28MFY2024FY2025 Revenue: $52M — margin split not shown (non-operating gains)$52MFY2025
  • Net income
  • Taxes & interest
  • Operating costs
  • Net loss year
Annual revenue; bands show net, operating margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity
Source: SEC EDGAR · Filed 2026-07-16
Most recent filed transactions — July 2026:
  • 2026-07-1610% OwnerTender-412,000—
  • 2026-07-1610% OwnerTender-3,635,758—
  • 2026-07-1610% OwnerTender-2,773,545—
Sign in to see all transactions →

Company news

View all →

Questions this page answers

What does XOMA Royalty Corp. do?

XOMA is a royalty aggregator that provides non-dilutive funding to biotech companies in exchange for the right to receive future milestone and royalty payments from their drug candidates and approved products.

When did XOMA last file with the SEC?

XOMA Royalty Corp.'s most recent SEC filing on record is a 8-K filed 2026-07-14. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 07:15 UTC. This page is also available as JSON at /api/data?ticker=XOMA and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for XOMA and 5,000+ tickers.

Create a free account — keep XOMA
For your agent
GET /api/data?ticker=XOMA

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt